Concepedia

Pauline Bollen

PB

6

Publications

192

Citations

6

H-Index

2018

Active since

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Medical Research Council

University College London

Joint Clinical Research Centre

Pauline Bollen is an author at Radboud University Nijmegen specializing in hiv, medicine, and virology.

Top concepts

Publications per year

2018–2022

6

Publications

6

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

Pauline Bollen, Cecilia L. Moore, Hilda Mujuru et al. · The Lancet HIV · 2020 · 46 citations · Full text

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma

Pauline Bollen, Marga J. A. de Graaff-Teulen, Stein Schalkwijk et al. · Journal of Chromatography B · 2018 · 42 citations

, , +12

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Hylke Waalewijn, Man K. Chan, Pauline Bollen et al. · The Lancet HIV · 2022 · 37 citations · Full text

, , +6

The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus

Pauline Bollen, Jolien J. M. Freriksen, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2020 · 34 citations

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 23 citations · Full text

Rows per page

1–5 of 6